So what your saying is, is this is gonna go like this for a long, long, time.He will sell his shares at 5 or 6 cents until all 7 million, or whatever is gone. Which could take years. Not much of a chance for this stock to go over 5 or 6 cents, because he just keeps it held down, where he can pick his pennies over and over.Not much of an incentive for a person to invest in this stock. What say you?
He has been in the deal all along this is just another 7 million shares under another account. Obvious someone is a big seller in this and anyone with that many shares has to be close to the company one way or another.
someone mentioned they can't sell the shares from the tommy deal awhile back until October. Not sure if that's true or not. If that's the case, look for the volume on the ask to be in the millions for a long time.
This whole deal is a cash register for management and friends. Orion one Global used to be Globatom both owned by Tommy Stephenson. Why does Heated details need to sell so much stock at 6 cents? Does he not have funding for Orion One Global? They don't file because they have an ATM machine here. All these announcements and no revenue what does that tell you. After he sells his 7 million shares he will come up with another company and bogus deal to get more shares
Well, this guy selling 7 million shares everyday for a few hundred dollars, siphoning off every day. In other words, if your a long term investor here, just bend over, cause here it comes. I'm more concerned about this late filing. Have any other company filed for late filings? Is the company using this Corona Virus crisis to delay bad news or what?
Figured it was heated details selling millions of shares. If the guy was a real player he wouldn't dump his 4 or 7 million shares at 6 cents to get paid a few hundred thousand. As an insider doesn't show much conviction on the direction of management and the long term prospects of the company
The company allowed the new director to convert 4m shares to settle debt with him on Sept 2. Chances are it's him selling his shares.
Who is the huge seller there is always big size on the offer never goes away?
NXT Water Officially Launches AKESO Hemp Powered Hydration in Conjunction with New Management, Investment Capital and Distribution
TTTSF: TruTrace Technologies Inc. Announces Postponement in Filing of Annual Filings
Toronto, Ontario – August 28, 2020, TruTrace Technologies Inc. (CSE: TTT; OTCQB: TTTSF) (“TruTrace” or the “Company”), creator of a fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry announces that it will not be in a position to file its audited annual financial statements for the fiscal year ended April 30, 2020 and the related management's discussion and analysis, as required by Part 4 and Part 5 of National Instrument 51-102: Continuous Disclosure Obligations (collectively, the "Annual Filings") by the filing deadline of August 28, 2020.
This news release is being issued in accordance with the blanket relief of a 45-day extension, provided by Canadian Securities Administrators and Ontario Instrument 51-502: Temporary Exemption from Certain Corporate Finance Requirements, for periodic filings normally required to be made by issuers.
In response to recent proclamations from Canadian health authorities and the challenges resulting from the COVID-19 pandemic, the Company has taken the necessary precautions to protect the health and safety of its employees and the public. Accordingly, a significant portion of the Company's staff as well as its auditor's staff have been working from home, and travel for in-person meetings has been curtailed. While working remotely, the coordination of tasks and work product has been more difficult, the completion of audit procedures due to limited access to paper-based supporting evidence has been delayed, and the entire audit process has been slowed. Furthermore, since the Company's various suppliers and clients have also been working remotely, their responses to standard audit inquiries have slowed, including responses from significant Company clients.
The challenges posed by COVID-19 have resulted in a delay in the finalization and filing of the Annual Filings. However, the Company's board of directors and its management confirm that they are working expeditiously to meet the Company's obligations relating to the filing of the Annual Filings. At this time, the Company anticipates being able to complete the Annual Filings on or before October 12, 2020.
The Company confirms that its management and other insiders are subject to an insider trading black-out policy that reflects the principles in section 9 of National Policy 1 1-207: Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions, such that they are in a black-out period until the end of the second trading day after the Annual Filings have been disclosed by way of a news release.
Since March 27, 2020, the date of filing of the Company’s unaudited interim financial statements for the three months ended January 31, 2020, the Company has announced:
On June 26, 2020, the Company announced that it settled CAD $950,000 of indebtedness previously owed to Heated Details, Inc., the primary vendor responsible for software development, design and maintenance of the Company’s proprietary StrainSecure™ platform and thereby securing all rights to TruTrace’s intellectual property.
On July 3, 2020, the Company announced it signed a software license agreement with OrionOne Global, Inc., a global supply chain provider delivering best-in-class technology which serves as a logistics and tracking smart-hub for navigating shipments and logistics worldwide.
On July 3, 2020, the Company announced the acquisition, by way of private transactions, of control and direction over an aggregate of 17,200,000 common shares in the capital of the Company by Thomas Stephenson, Chief Technology Office of the Company.
On August, 14, 2020, the Company advised the Security Holders that the Annual General and Special Meeting of the Company is to be held on October 16, 2020
On August 25, 2020, the Company announced that it teamed with Riviera & West One Logistics to ensure the highest quality for its line of products including Hygen-X™ hand and surface sanitizer products.
On August 26, 2020, the Company announced that medical distributor, Safe Company selected the TruTrace Enterprise™ SaaS platform to manage inventory and quality assurance processes for its medical and protective consumables, hospital supplies and air purification solutions.
The Canadian Securities Exchange has not reviewed this news release and does not accept responsibility for the adequacy or accuracy of this news release.
On behalf of the Board of Directors: Robert Galarza, Chief Executive Officer and DirectorFor More Information: Robert Galarza, Chief Executive Officer and Director, 888-775-4888
Disclaimer for Forward-Looking Information This news release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. Forward-looking statements made in this news release relate to the anticipated timing of the Annual Filings. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including adverse market conditions. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this
notice. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities la
then could possibly be shorting shares against his position
someone mentioned they weren't allowed to sell the shares until October but no clue if that's true.
You can get filled all day long at the HUGE offer. So who is the big seller in this at 5 and 6 cents? Probably the 7.7 mm shares they just gave away.The PR releases all look good but this trades like a printing press.
Even a glimmer of hope in the fins would please me. I know we're both checking Sedar every day for the filing!
Wow, that's nice! I haven't been able to get a fill at all, and some others had problems too. I finally put on in at the ask and get filled. Hoping for a solid report somehow for the 4th quarter and we won't look back at these prices ever again.
Interesting. Put 2K order in with limit at Ask of .053. Filled at .04665. Have placed a few orders in last few weeks and they always fill well below the Ask.
Didn't quite see any on his twitter. They were on the last deck so I assume they were a part of it. I originally thought they had a subsidiary a part of it but don't remember.
garettf, has Rob followed any of the APHA folks? They haven't announced participation in the Trial, though they were original members last year when this project started. Wondering because of this article: https://www.prnewswire.com/news-releases/aphria-inc-announces-strategic-supply-agreement-with-canndoc-301105647.html
Only difference between this meeting and the filing for the one last year is:
Issuer sending proxy related materials directly to NOBO: yes.
There were no proxy materials last year.
What does the Sedar filing on August 14th mean? A meeting for the common shareholders coming up. Just normal director voting or more...?
August 14, 2020 510 Burrard St, 3rd Floor
Vancouver BC, V6C 3B9
To: All Canadian Securities Regulatory Authorities
Subject: TRUTRACE TECHNOLOGIES INC
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
Meeting Type : Annual General and Special Meeting
Record Date for Notice of Meeting : September 09, 2020
Record Date for Voting (if applicable) : September 09, 2020
Beneficial Ownership Determination Date : September 09, 2020
Meeting Date : October 16, 2020
Meeting Location (if available) : Vancouver, BC
Issuer sending proxy related materials directly to NOBO: Yes
Issuer paying for delivery to OBO: No
Notice and Access (NAA) Requirements:
NAA for Beneficial Holders No
NAA for Registered Holders No
Voting Security Details:
Description CUSIP Number ISIN
COMMON 898447107 CA8984471075
Per Sedar, last year's full year financials were posted August 23rd I believe. So we'll get some kinda soon hopefully.
When was the last financials posted? Are we due some financial reports? Maybe I missed the last ones.
They probably find ways around it. Just looks like a lot of size always
200k + on the offer. Who has that kind of size to keep selling at 6 cents?
I could be wrong but I think I heard someone say there is a lockup period on the shares for a few months. Someone correct me if that's wrong.
I get the feeling the covid tracing app stuff will come first and then this will catch fire.
Just a wild guess
Beautiful presentation, garrettf. Thanks.
Have you seen the new investor deck? Out a few days ago. Discusses tracking Cannabis, pharmaceuticals, pharmaceuticals, cosmetics, and food. If they start to sign a deal in any of those areas, this stock will explode. That would mean getting into industries in the US that aren't illegal. We'll see what happens over the rest of the year if it's the real deal.
I'm thinking Shoppers Drug Mart/TruTrace collaboration eventually could lead to blockchain tracking for pharmaceuticals.
This is an old article, but still very relevant.
"How Pharma will soon use Blockchain to track your drugs"
all good! Thank you for posting all the news. I try to as well when I'm free. Lot of news lately, let's see if it keeps on rolling in.
LOL, sorry for the double Radient post!
Radient Technologies Inc. Announces Participation in a Medical Cannabis Study Led by the University Health Network in Partnership with Shoppers Drug Mart
EDMONTON, Alberta, July 17, 2020 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a manufacturer of high quality cannabinoid-based formulations and products, is pleased to announce that bioU products by Radient will be available to patients in the recently announced University Health Networks’ (“UHN”) Medical Cannabis Real-World Evidence Study (“MC-RWE Study”) in partnership with Medical Cannabis by Shoppers. The first-of-its-kind study will involve a nation-wide clinical trial to examine the effects of medical cannabis on pain, sleep and anxiety issues.
Radient developed the bioU brand exclusively for Medical Cannabis by Shoppers and the products have been formulated to meet the highest levels of quality, consistency, and stability. All three oral spray formulations currently available on the Medical Cannabis by Shoppers site will be available to patients enrolled in the MC-RWE Study, providing patients with a variety of options in THC and CBD products in a convenient and standard dose format. As part of the study, all bioU products have undergone additional testing, with results registered on TruTrace Technologies software platform and integrated with the Medical Cannabis by Shoppers.
“Radient strongly believes that consistency, safety and standardization are key elements for all medical products, and are excited to partner with UHN, Shoppers and TruTrace on this groundbreaking study,” said Denis Taschuk, CEO of Radient Technologies. “Providing patients and medical professionals with trusted products that deliver repeatable results is a crucial step in having cannabis incorporated into medical treatments and is at the heart of all Radient products. Shoppers is creating a standard for medical cannabis, which along with the data from these clinical trials, will increase the confidence of both doctors and patients in using cannabis for medical purposes.”
About the UHN MC-RWE Study
Led by UHN's Dr. Hance Clarke, the observational study is targeting a minimum of 2,000 patients who will be followed over a 24-week period. Enrolled patients will have access to certain fully verified products on the Medical Cannabis by Shoppers platform, which have been tested for detailed cannabinoid and terpene profiles. Read more about the study here.
Radient Technologies is a commercial manufacturer of high quality cannabinoid based formulations, ingredients and products. Utilizing a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant, Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Please visit www.radientinc.com for more information.
SOURCE: Radient Technologies Inc.
For further information please contact:
Radient - Investor Relations
Forward Looking Information:
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations; the Company’s participation in the MC-RWE Study; the Company’s ability to grow its business in the cannabis sector and the Company’s future plans. G